The Market
SWOT Analysis
Strengths
Proven Experience :
- Commercial launch 400 Hospitals and 400 Communities in China
- 7x Patents and 11x Patents Application in Process with 34 awards in Hong Kong and China
- Governments supporting in Beijing, Shenzhen, Jiangmen, Zhongshan and Hong Kong.
- Nearly US$600K+ funding in China and Hong Kong
Uniqueness :
- Improve Pharmacy Operation Efficiency by our 1st 3-in-1 RDDE of Refilling (Intelligence Verification), Extracting (Precise Robotic Clip and Arm) and Automatic Dispensing based on AI technology
- 7×24 for Handling Prescription and non-Prescription Services
Weaknesses
Lack of Resources Allocation :
- Recruitment of new Team members / Advisory Board for enhance Healthcare operation knowhow
- International Patent Application
- Funding for Global Expansion in Asian, EMEA and European Countries
- Lack of Business Case outside Hong Kong and China
Opportunities
- Pharmacy Automation for Healthcare Services Providers on Prescription and Non-Prescription Services
- AI Powered Customer Analytics for Government, Pharmaceutical and Insurance
- Standardize Blister Pack and Avoid 2nd line Therapeutic Drugs
- Integrate Mobile App with Telemedicine / Online Ordering of Drugs
- Cater for the future development on Chinese Medicine
Threats
- Decision making may be delayed by Government and Pharmaceutical
- Longer adaptation period will be expected for create new business strategies and project implementation
- Longer revamping for system architecture design and migration processes due to existing system built by mix of multi-vendor and in-house development
Market Viability

